Molly Nikolas

Professor with expertise in the intricate dynamics of psychological disorders, Dr. Molly Nikolas serves as an Associate Professor in the Department of Psychological and Brain Sciences at the University of Iowa. With a keen focus on the complexities of attention-deficit hyperactivity disorder (ADHD) and its co-occurring disruptive behavior disorders, she has made significant strides in understanding the underlying causal processes. Her work is pivotal in identifying genetic variants and the gene-environment interplay that contribute to these conditions. Dr. Nikolas is the Director of the Iowa ADHD and Development Laboratory, where she leads a team dedicated to unraveling the genetic and environmental factors influencing ADHD. Her research employs a multifaceted approach, utilizing genetic, cognitive, psychophysiological, behavioral, and informant report measures. This comprehensive methodology allows her to explore both risk and protective factors associated with ADHD and its comorbid conditions, providing a holistic view of the disorder. In addition to her research endeavors, Dr. Nikolas is the Director of Clinical Training for the Clinical Science PhD program at the University of Iowa. In this role, she is instrumental in shaping the next generation of clinical scientists, ensuring they are equipped with the necessary skills and knowledge to advance the field of psychological sciences. Dr. Nikolas's contributions to the field are not only academic but also practical, as her research has implications for developing targeted interventions and treatments for individuals with ADHD. Her work is characterized by a commitment to bridging the gap between genetic research and clinical application, aiming to improve outcomes for those affected by these disorders. Her dedication to understanding the gene-environment interplay in ADHD has positioned her as a leading figure in psychological research. Through her innovative studies, Dr. Nikolas continues to push the boundaries of what is known about ADHD, offering new insights and potential pathways for treatment and prevention.